Casey M. Tansey - 16 Jan 2024 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Director
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Casey M. Tansey
Issuer symbol
INSP
Transactions as of
16 Jan 2024
Net transactions value
+$16,185
Form type
4
Filing time
18 Jan 2024, 20:43:45 UTC
Previous filing
17 Oct 2023
Next filing
16 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Gift $0 -500 -2.5% $0.000000 19,895 25 Aug 2023 Direct
transaction INSP Common Stock Gift $0 -500 -2.5% $0.000000 19,395 25 Aug 2023 Direct
transaction INSP Common Stock Gift $0 +500 $0.000000 500 25 Aug 2023 By Family Trust F1
transaction INSP Common Stock Gift $0 +500 $0.000000 500 25 Aug 2023 By Family Trust F2
transaction INSP Common Stock Award $652 +2 +0.01% $325.91 19,397 16 Jan 2024 Direct F3
transaction INSP Common Stock Award $1,204 +8 +0.04% $150.47 19,405 16 Jan 2024 Direct F4
transaction INSP Common Stock Award $14,330 +77 +0.4% $186.10 19,482 16 Jan 2024 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held by The Kimberly Tansey Irrevocable Trust.
F2 Securities held by The Kylie Tansey Irrevocable Trust.
F3 Represents settlement of shares of Common Stock issued in lieu of cash fees to which the Reporting Person was previously granted pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023 and inadvertently not previously issued due to a clerical error.
F4 Represents settlement of shares of Common Stock issued in lieu of cash fees to which the Reporting Person was previously granted pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023 and inadvertently not previously issued due to a clerical error.
F5 Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.